Navigation Links
Scientists Discover Protein Involved in Fat Production
Date:6/12/2008

Mouse experiments might lead to new target for treating high cholesterol, researchers say

THURSDAY, June 12 (HealthDay News) -- In experiments with mice, researchers have found a protein in the liver involved in regulating the production of fat molecules.

The finding could provide a new target for treating high cholesterol or fatty liver disease.

"We identified a novel transcription factor that regulates lipid synthesis in the liver," said lead researcher Ann-Hwee Lee, from the Harvard School of Public Health. "This transcription factor is activated in response carbohydrate intake."

This protein, called XBP1, is another key transcription factor regulating lipid production in the liver in response to high carbohydrate intake, Lee said. "So, mice that do not have XBP1 have dramatically reduced plasma lipids, such as cholesterol and fatty acids," he explained.

Lee's team found this protein switches genes involved in fat metabolism on and off.

The report is published in the June 12 online edition of Science.

In the current study, Lee's group used mice that had no XBP1 expression in the liver. These mice showed lower levels of cholesterol and fatty acids in the blood because of reduced production of fats.

This discovery could lead to new ways for treating high cholesterol, Lee said.

"We hope by controlling this pathway, we may be able to control the human diseases caused by increased levels of lipids," Lee said.

Any drug that would target XBP1 would work differently than statins, Lee noted. "The advantage of a drug that targets XBP1 is that it controls both cholesterol and fatty acids," he said.

However, there is also a big disadvantage to such a drug, Lee said.

"Unfortunately, XBP1 is expressed everywhere in the body, and it has a dual function," Lee said. "It controls lipids, but it also has a role in protein secretion. So, any drug that eliminates XBP1 not only reduces lipids, but it also interferes with the normal functioning of cells. So, we would have to find a drug-delivery system that specifically targets XBP1 in the liver."

One expert thinks this finding could lead to new ways to reduce fats linked to cardiovascular and other diseases.

"The main findings of this paper was the unexpected consequences of this protein," said Dr. Jay D. Horton, the Dr. Robert C. and Veronica Atkins Chair in Obesity and Diabetes Research and a professor of internal medicine, digestive and liver diseases at the University of Texas Southwestern Medical Center at Dallas. He also authored an accompanying journal editorial.

"This protein provides a potential new target for reducing cholesterol and fat synthesis in the liver, which could have a positive impact on certain disease processes, such as high cholesterol and high triglyceride levels in the blood," Horton said.

Such a drug could also help treat fatty liver disease, which is a condition where there is too much fat in the liver, Horton said.

"However, how this would work in humans isn't known, and neither is the safety of such a drug," Horton said.

More information

For more on cholesterol, visit the U.S. National Library of Medicine.



SOURCES: Ann-Hwee Lee, Ph.D., Harvard School of Public Health, Boston; Jay D. Horton, M.D., Dr. Robert C. and Veronica Atkins Chair in Obesity and Diabetes Research, and professor, internal medicine, digestive and liver diseases, University of Texas Southwestern Medical Center at Dallas; June 12, 2008, Science, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Discover Protein Involved in Fat Production 
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: